← Search another ETF⎙ Printable sheet (PDF)
ETF sheet · Issuer-declared data
🇮🇹 Effective capital-gains rate: 26.00%details →

Amundi S&P World Health Care Screened UCITS ETF DistIndex, costs, backtest, listings and taxation

ISIN: IE000JKS50V3Ticker: WELZ (Xetra)Issuer: AmundiClass: UCITS ETF Dist
Issuer-declared data
Declared index
S&P World Health Care Weighted & Screened Index
TER
0.18%
Transaction costs
0.07% (issuer estimate, from the KID)
Management
Passive (index-tracking) (from the KID)
Replication
Income policy
SFDR
Article 8 — promotes environmental or social characteristics what does it mean?
Sector (from holdings)
Health care100% of the declared portfolio (31 July 2026)
Fund assets
134.3 mln EUR
NAV
11.57 EUR (1 September 2026)
Domicile
Ireland
Inception date
20 September 2022
Data as declared by Amundi in the issuer’s official files and endpoints · collected on 2 September 2026 (monthly refresh). Facts only, no recommendation.
📬 Follow the engine as we build it

One email when new issuers, new metrics and new articles land. Double opt-in, zero spam, one-click unsubscribe.

Description

Amundi S&P World Health Care Screened UCITS ETF Dist tracks the issuer-declared index: S&P World Health Care Weighted & Screened Index. The declared annual cost (TER) is 0.18%, plus 0.07% in transaction costs estimated by the issuer in the KID. Replication is direct physical replication; income is distributed to investors. The fund has assets of about 134 million euro, was launched on 20 September 2022 and is domiciled in Ireland. In our registry 1 other ETFs declare the same index.

The fund’s objective — in the issuer’s words

The Sub-Fund is passively managed. The objective of the Sub-Fund is to track the performance of the S&P World Health Care Weighted & Screened Index (the "Index"). The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Sub-Fund promotes environmental and/or social characteristics through among others, replicating an Index integrating an environmental, social and governance ("ESG") rating. The Index is an equity index that measures the performance of eligible equity securities from the S&P World Health Care Index (the "Parent Index"). The Parent Index is designed to measure the performance of large and mid-cap health care companies in developed markets excluding Korea which make up approximately 85% of the total available capital. Health care companies are identified by reference to the GICS. The health care sector includes health care providers and services, companies that manufacture and distribute health care equipment and supplies, and health care technology companies. It also includes companies involved in the research, development, production and marketing of pharmaceuticals and biotechnology products. The Index is selected and weighted to enhance ESG profiles, and reduce carbon emission intensity, all compared to the Parent Index. The Index applies several ESG filters (e.g. exclusions filters to exclude companies involved in controversial business activities (e.g. controversial weapon), or involved in ESG controversies) and optimization constraints (GHG intensity reduction and identical S&P Global ESG Score or improvement of such score compared to the Parent Index). The Index is a net total return index, meaning that dividends net of tax paid by the index constituents are included in the Index return. More information about the composition of the Index and its operating rules are available in the prospectus and at https://www.spglobal.com/spdji/en/supplemental-data/europe The Index value is available via Bloomberg (SPDSEHUN). The exposure to the Index will be achieved through a direct replication, mainly by making direct investments in transferable securities and/or other eligible assets representing the Index constituents in a proportion extremely close to their proportion in the Index. The Investment Manager will be able to use derivatives in order to deal with inflows and outflows and which relate to the Index or constituents of the Index for investment and/or efficient portfolio management. In order to generate additional income to offset its costs, the Sub-Fund may also enter into securities lending operations.

Keep reading the KID section ▾

Intended Retail Investor:This product is intended for investors, with a basic knowledge of and no or limited experience of investing in funds seeking to increase the value of their investment over the recommended holding period with the ability to bear losses up to the amount invested.

Redemption and Dealing:The Sub-Fund's shares are listed and traded on one or more stock exchanges. In normal circumstances, you may deal in shares during the trading hours of the stock exchanges. Only authorised participants (e.g., selected financial institutions) may deal in shares directly with the Sub-Fund on the primary market. Further details are provided in the AMUNDI ETF ICAV prospectus.

Distribution policy:The Fund’s amounts available for distribution (if any) will be distributed.

More Information:You may get further information about the Sub-Fund, including the prospectus, and financial reports which are available at and free of charge on request from: Amundi Ireland Limited at AMUNDI IRELAND LIMITED, One George's Quay Plaza, George's Quay, Dublin 2, Ireland.

From the KID’s “Objectives” section · 4 August 2026 · original document ↓
Text generated from the data the issuer declares in official product lists. No recommendation.

Quick reads

  • TER 0.18%: below the median of equity ETFs we track (0.22%).
Comparisons computed by Rebalix on the declared data in our census; they describe the past and are not indicative of future results.

Official documents

Key Information Document (KID)PDF in English, from the issuer’s site — always the latest filed versionProspectusPDF in English, from the issuer’s site — the fund’s full legal documentFactsheetPDF in German, from the issuer’s site — the fund’s monthly snapshot
The KID is the document the law requires you to read before investing: 3 pages covering risks, costs and scenarios. The link opens the issuer’s published PDF.

Fund performance

issuer-declared net asset value (NAV) · EUR · from Sept 2022 to Sept 2026
Compare with another ETF
Only funds we hold a history for. Three at a time, at most.
Return
+16.2%
Annualised
+3.9%
Volatility (ann.)
13.4%
Max drawdown
-22.58%
-7%+2%+10%+19%+28%Sept 2022Sept 2023Sept 2024Sept 2025Sept 2026The break-even line: the value at the start of the period. Above it you are in gain, below in loss.break-even (0%)+16%Sept 2022Sept 2026
Tip: drag across the chart to zoom into a period.

Drawdown — distance from previous peak

This isn’t the return: it shows how far the fund is below its previous peak. 0% = you’re at the peak; below zero = how much you’re down and haven’t recovered yet.
0%-5%-10%-15%-20%-25%-30%20222023202420252026−22.58% · 07 Aug 2025
Max drawdown
-22.58%
peak → trough
Trough
07 Aug 2025
from the 30 Aug 2024 peak
Recovery time
not yet
recovery only: trough to break-even
Underwater
739 days
decline + recovery: peak to break-even · ≈ 2 years · (ongoing)

The five worst falls in the period

From the peak ofTroughDepthBack to break-evenDays underwater
30 Aug 202407 Aug 2025-22.58%ongoing739
30 Nov 202210 Mar 2023-11.12%04 Jan 2024400
01 Aug 202405 Aug 2024-4.74%16 Aug 202415
28 Mar 202418 Apr 2024-4.38%05 Jun 202469
31 Oct 202216 Nov 2022-4.11%30 Nov 202230

Calendar-year returns

2022
2.4%
2023
2.1%
2024
7.8%
2025
0.3%
2026
2.8%

Month-by-month returns

JanFebMarAprMayJunJulAugSeptOctNovDecYear
2026-1.22.9-6.7-1.32.56.40.62.7-2.52.8
20256.11.8-5.5-7.3-4.6-1.8-1.12.80.35.17.4-1.80.3
20244.52.32.7-2.30.93.92.43.4-4.3-2.31.5-4.67.8
2023-2.7-1.30.92.1-0.60.10.71.00.3-2.81.92.72.1
20227.60.8-4.82.4
From month-end NAVs, over the fund’s full history, on the series shown in the chart (dividends reinvested where declared). Deeper colour = larger move.
Issuer-declared series with dividends reinvested: the total performance, comparable with accumulating funds. Switch it off to see the price (NAV) alone, which drops at every dividend payment.
Source: Amundi. Issuer-declared historical series; inflation: Eurostat and national statistical institutes, latest available July 2026 — for later days the index stays at the last published value (institutes publish with a few weeks’ lag). The «adjusted for inflation» view expresses value in today’s purchasing power for the selected country; volatility always stays nominal, as elsewhere on the site (deflating it would add artificial swings caused by the monthly cadence of the price index). Past performance is not indicative of future results: these are facts, not a recommendation.

Tracking difference — fund vs index

How much the fund returned above (+) or below (−) its index, year by year. It measures the actual deviation: the combined effect of costs (TER and transaction), securities-lending revenue and replication optimisations — which is why it can beat the TER.
Declared TER
0.18%
YearFundIndexDifference
2025+0.31%+0.24%+0.08%
2024+7.82%+7.76%+0.06%
Fund return with dividends reinvested by Rebalix on each ex-date (the issuer does not publish a total-return series); index from the issuer-declared series; complete calendar years covered by our dividend archive. complete calendar years. TD is not comparable across sites using different methodologies or index variants. Past performance is not indicative of future results. What is tracking difference? →

Risk indicators· EUR

Last yearLast 3 yearsFull history
Volatility (ann.)15.28%13.65%13.39%
Max drawdown-13.43%-23.57%-23.57%
Sharpe0.670.030.04
Sortino1.070.040.06
Windows longer than the available price history cannot be computed and are not shown: they will appear on their own as time passes. Computed from the daily NAV series, always in nominal terms. Sharpe and Sortino use the ECB main refinancing rate averaged over the period (last year: 2.21%), weighted by days in force, as the risk-free rate. Same formulas as our public methodology: sample standard deviation annualised over 252 days; Sortino with downside deviation. Past performance is not indicative of future results. Figures in EUR, the fund's currency; the table follows the currency selected in the chart.

Portfolio holdings

Securities in portfolio
85
Top-10 weight
52.6%

Top 10 holdings

ELI LILLY & CO · LLY UN
11.40%
ABBVIE INC · ABBV UN
8.07%
MERCK & CO. INC. · MRK UN
5.53%
NOVARTIS AG-REG · NOVN SE
4.92%
UNITEDHEALTH GROUP INC · UNH UN
4.59%
ASTRAZENECA GBP · AZN LN
4.15%
AMGEN INC · AMGN UW
4.02%
ROCHE HOLDING AG - GENUSSS CHF · ROP SE
3.74%
GILEAD SCIENCES INC · GILD UW
3.42%
THERMO FISHER SCIENTIFIC INC · TMO UN
2.80%

Sectors

Health Care
100.0%

Countries

AfghanistanAngolaAlbaniaUnited Arab EmiratesArgentinaArmeniaFrench Southern and Antarctic LandsAustralia: 0.9%AustriaAzerbaijanBurundiBelgium: 1.6%BeninBurkina FasoBangladeshBulgariaThe BahamasBosnia and HerzegovinaBelarusBelizeBoliviaBrazilBruneiBhutanBotswanaCentral African RepublicCanadaSwitzerland: 10.1%ChileChinaIvory CoastCameroonDemocratic Republic of the CongoRepublic of the CongoColombiaCosta RicaCubaCyprusCzech RepublicGermany: 0.4%DjiboutiDenmark: 2.7%Dominican RepublicAlgeriaEcuadorEgyptEritreaSpainEstoniaEthiopiaFinland: 0.2%FijiFalkland IslandsFrance: 1.5%GabonUnited KingdomGeorgiaGhanaGuineaGambiaGuinea BissauEquatorial GuineaGreeceGreenlandGuatemalaFrench GuianaGuyanaHondurasCroatiaHaitiHungaryIndonesiaIndiaIreland: 0.2%IranIraqIcelandIsrael: 0.1%Italy: 0.1%JamaicaJordanJapan: 2.6%KazakhstanKenyaKyrgyzstanCambodiaSouth KoreaKosovoKuwaitLaosLebanonLiberiaLibyaSri LankaLesothoLithuaniaLuxembourgLatviaMoroccoMoldovaMadagascarMexicoMacedoniaMaliMyanmarMontenegroMongoliaMozambiqueMauritaniaMalawiMalaysiaNamibiaNew CaledoniaNigerNigeriaNicaraguaNetherlandsNorwayNepalNew Zealand: 0.2%OmanPakistanPanamaPeruPhilippinesPapua New GuineaPolandPuerto RicoNorth KoreaPortugalParaguayQatarRomaniaRussiaRwandaWestern SaharaSaudi ArabiaSudanSouth SudanSenegalSolomon IslandsSierra LeoneEl SalvadorSomaliaRepublic of SerbiaSurinameSlovakiaSloveniaSweden: 0.3%SwazilandSyriaChadTogoThailandTajikistanTurkmenistanEast TimorTrinidad and TobagoTunisiaTurkeyTaiwanUnited Republic of TanzaniaUgandaUkraineUruguayUnited States of America: 73.8%UzbekistanVenezuelaVietnamVanuatuWest BankYemenSouth AfricaZambiaZimbabwe
up to 1%1–5%5–15%15–30%over 30%
Hover a country for its percentage.
Top 7 countries
United States73.8%
Switzerland10.1%
United Kingdom5.4%
Denmark2.7%
Japan2.6%
Belgium1.6%
France1.5%
Download the full portfolio — Excel, 86 rows
Full portfolio declared by Amundi, as of 1 September 2026: this is the summary. Percentages may not sum to 100 due to cash, derivatives and rounding.
Fund historyFund-assets (AUM) chart year by year and monthly basket snapshots.Open the history →

Dividends

Frequency
Annual
Latest dividend
0.163 EUR
ex 10 Feb 2026 · paid ~13 Feb 2026
Dividends, last 12 months
0.16 EUR
Dividend yield
1.46%
12-month sum over the NAV as of 8 Sept 2026

Yield by year

PeriodDividendsDividend yield
1 year0.16 EUR1.64 %
20250.15 EUR1.35 %
20240.10 EUR0.97 %
20230.02 EUR0.18 %

Dividend contribution to total return

-10%0%10%20%+13.81 %1 year+0.38 %2025+7.82 %2024+2.14 %2023
dividendsprice changeprice decline

Calendar per share (EUR)

YearJanFebMarAprMayJunJulAugSepOctNovDec
20260.16
20250.15
20240.10
20230.02

Latest dividends

Per shareEx-dividend datePayment
0.163 EUR10 Feb 202613 Feb 2026 · estimated
0.151 EUR12 Feb 202517 Feb 2025 · estimated
0.1017 EUR14 Feb 202419 Feb 2024 · estimated
0.0181 EUR15 Feb 202317 Feb 2023 · estimated
Per-share dividends as declared by the issuer, in EUR, since the first payment (15 Feb 2023). Past dividends are not indicative of future ones. An «estimated» payment date is computed by Rebalix (ex-date + 2-3 business days, as this issuer has paid in the past) because the issuer does not publish it: it may differ by a day.

ETFs declaring the same index

FundTERIncomeFund size
WELS · Amundinot on Borsa Italiana
0.18%Acc.564 mln EUR
2 ETFs in our census declare this index (including this fund). Funds declaring the exact same index, word for word, in official product lists. Differently-worded variants (or other index versions) are not shown: a short list beats a wrong match. Sorted by TER. A dash “—” = not declared by the issuer in the files we read — not a zero.

Italian taxation

Effective rate on capital gains
26.00%
White-list share
0.00%
From the government-bond («white list») share certified by the issuer every semester: 12.5% on that portion, 26% on the rest.
Deep-dive into this fund’s taxation →

Where it shows up commission-free in Italy

According to the official lists published by the brokers (downloaded and cross-checked by us), these share classes of the fund appear tradable with zero fees:

IE000JKS50V3WELZ
  • XTBzero (up to €100,000 monthly volume, unreachable for a retail plan); fractions available in plans
Full terms, traps and method in the observatory: Free savings plans and zero-commission ETFs: the broker survey

Official lists verified on 3 September 2026. We record published terms — this is neither an invitation to open accounts nor a recommendation: lists change, the broker’s documents prevail. Trade Republic, Scalable Capital and Trading 212 publish no per-ISIN lists and don’t appear here.

Stock exchange listings

ExchangeTickerTrading since
Börse Düsseldorf12 Oct 2022
Börse Frankfurt11 Oct 2022
Börse Hamburg6 Dec 2022
Börse Hannover9 Dec 2024
Börse München / gettex11 Oct 2022
Börse Stuttgart26 Oct 2022
Tradegate Exchange20 Dec 2022
Xetra (Deutsche Börse)WELZ11 Oct 2022
+ 15 more trading venues (MTFs and professional platforms).
Trading venues from the official ESMA register (FIRDS); per-exchange tickers from the issuer’s tax documents and official listings. A dash “—” = that venue does not publish the item (ticker, currency or start date) in the sources we read. The same fund may trade in different currencies depending on the exchange: check the trading currency with your broker. Non-EU listings (e.g. UK, Mexico) not included.

Frequently asked questions

Which index does Amundi S&P World Health Care Screened UCITS ETF Dist track?
The issuer Amundi declares the benchmark: S&P World Health Care Weighted & Screened Index.
How much does WELG cost?
The issuer-declared TER is 0.18% per year; the transaction costs estimated in the KID are 0.07%.
How is WELG taxed in Italy?
On sale, the capital gain is taxed at an effective 26.00% rate (white-list share 0.00%): 12.5% on the government-bond “white list” portion, 26% on the rest.
What is the fund size of WELG?
The fund size declared by Amundi is about 134 million euro.
When was WELG launched?
The fund was launched on 20 September 2022: it has 3 years of history.
How does WELG replicate its index?
It is a passively managed ETF: it follows the declared index. Physical (issuer wording: “Direct(Physical)”).
Does WELG pay dividends?
Yes: it is a distributing share class — income is paid out periodically (issuer wording: “Distribution”).
Where does WELG trade?
Per the official ESMA register it trades on 8 main exchanges, including Xetra (Deutsche Börse) (WELZ).
What was WELG's worst fall?
Over the available history (since 2022), the maximum drawdown was -23.57%, reached in August 2025. Past performance is not indicative of future results.
How many securities does WELG hold?
The declared portfolio holds 85 securities; the top 10 positions weigh 52.6%.
Transparency note
The data in this sheet is declared by Amundi in the issuer’s official files and endpoints, collected by Rebalix with a monthly refresh; taxation derives from the issuer’s tax documents (Italian Law Decree 138/2011). This is factual information for informational purposes only: it is not financial or tax advice, nor an investment recommendation. Read the fund’s KID and prospectus before investing.